Document is current
Any future updates will be listed below
-
Authors
Santiago, Fabricio Rodrigues https://orcid.org/0000-0002-3830-8989
Celovska, Denisa https://orcid.org/0000-0002-6653-9397
Thomis, Sarah https://orcid.org/0000-0002-8491-6264
Blanc-Guillemaud, Vanessa https://orcid.org/0000-0003-4471-178X
Onselaer, Marie-Blanche https://orcid.org/0000-0002-2894-1369
Serifou, Soumeya
Yaltirik, Hurrem-Pelin
Bokuchava, Mamuka https://orcid.org/0000-0002-6719-1302
-
Funding
Funding for this research was provided by:
Servier
- License Information
-
More Information
Article History
Received: 28 May 2025
Accepted: 5 May 2026
First Online: 29 May 2026
Declarations
:
: Denisa CELOVSKA has received honoraria for lectures from Alfasigma, Amgen, Bayer, Boehringer-Ingelheim, Elly-Lilly, Novartis, Pfizer, and Servier. Sarah THOMIS, Mamuka BOKUCHAVA, and Fabricio Rodrigues SANTIAGO have no conflicts of interest to declare. Vanessa BLANC-GUILLEMAUD and Hurrem-Pelin YALTIRIK are employees of Servier, France. Marie-Blanche ONSELAER is an employee of Soladis Clinical Studies that received fees from Servier Medical Affairs to conduct this work. Soumeya SERIFOU is an employee of Soladis that received fees from Servier Medical Affairs to conduct this work.
: The data supporting study findings are available from the corresponding author upon reasonable request.
: Ethics approvals were not required for this systematic review, as it did not involve human participants or animals.
: Not applicable.
: Not applicable.
: Not applicable.
: Concept and design (all authors), data acquisition (Vanessa BLANC-GUILLEMAUD and Marie-Blanche ONSELAER), statistical analysis (Soumeya SERIFOU), interpretation of data for the work (all authors), drafting the manuscript (Marie-Blanche ONSELAER, Vanessa BLANC-GUILLEMAUD and Hurrem-Pelin YALTIRIK), review of manuscript (all authors), and final approval (all authors). All authors read and approved the final version and agree to be accountable for the work.
